Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2007
07/03/2007CA2218728C Compositions and methods for the rapid analysis of reticulocytes
07/03/2007CA2169121C Competitive immunoassay using complexed analyte derivatives
07/03/2007CA2145733C Monitoring water treatment agent in-system concentration and regulating dosage
07/03/2007CA2138213C Method of analysing drilling fluids
07/03/2007CA2092567C Nt-4 neurotrophic factor
06/2007
06/30/2007CA2572530A1 A method for determining the phenotype of cells
06/28/2007WO2007073411A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease
06/28/2007WO2007073355A1 A testing method for precious metals
06/28/2007WO2007073340A1 A method and a system for monitoring structural changes of a fiber web
06/28/2007WO2007073311A1 Preparation of biomolecules
06/28/2007WO2007073227A1 Diagnosis method, a device for carrying out said method and a serum preparation method
06/28/2007WO2007073220A1 Prognosis prediction for colorectal cancer
06/28/2007WO2007073139A1 Diagnostic diaper
06/28/2007WO2007073123A1 Determination of the absolute configuration of genomic feature and the coding regions with conserved polar asymmetry in genome
06/28/2007WO2007073107A1 Bio memory disc and bio memory disk drive apparatus, and assay method using the same
06/28/2007WO2007072990A1 Cassette and examination apparatus
06/28/2007WO2007072980A1 Novel application of apelin
06/28/2007WO2007072976A1 A method of producing a multimeric capture agent for binding a ligand
06/28/2007WO2007072975A1 Method for functionalising a hydrophobic substrate
06/28/2007WO2007072973A1 Novel capture agents for binding a ligand
06/28/2007WO2007072953A1 Blood-brain barrier in vitro model, pathologic blood-brain barrier in vitro model, drug screening method using the same, pathologic blood-brain barrier function analysis method and pathogenesis analysis method
06/28/2007WO2007072922A1 Immunoassay apparatus and method
06/28/2007WO2007072896A1 Method for prediction of prognosis of acute coronary syndrome
06/28/2007WO2007072866A1 Anti-ilt7 antibody
06/28/2007WO2007072724A1 METHOD OF DETECTING SUGAR CHAIN HAVING GlcNAc TRANSFERRED BY GnT-V
06/28/2007WO2007072645A1 Method of regulating cell size and/or cell cycle
06/28/2007WO2007072460A1 Sensing device and method for determination of the amount of target molecule in an analyte
06/28/2007WO2007072444A2 Biosensor device
06/28/2007WO2007072311A2 A sensor for biomolecules and a method for preparing and using the same
06/28/2007WO2007072197A1 Methods and systems for detecting and quantifying indirect thrombin inhibitors
06/28/2007WO2007072013A2 Cholesterol sensor
06/28/2007WO2007072011A1 Interleukin- 9 like receptor protein
06/28/2007WO2007072009A2 Container with rfid device for storing test sensors
06/28/2007WO2007071989A1 Micro-fluidic structures
06/28/2007WO2007071947A1 Cancer screening test
06/28/2007WO2007071927A2 Fluorescent dyes and complexes
06/28/2007WO2007071914A1 Markers
06/28/2007WO2007071874A2 Novel compounds which interact with pea-15
06/28/2007WO2007071851A1 Installation for candling eggs and optoelectronic system for examining under radiation in such an installation
06/28/2007WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies
06/28/2007WO2007071825A1 Measuring suspension
06/28/2007WO2007071824A1 Novel genes and markers associated with high-density lipoprotein -cholesterol (hdl-c)
06/28/2007WO2007071815A1 Method for monitoring and promoting the nutrition and well-being of an animal and/or a human being as well as the productivity of animals
06/28/2007WO2007071699A2 Methods for screening therapeutic efficacy of compositions in treatment of bone disease
06/28/2007WO2007071645A1 Screening compounds for activity in modulating chloride ion transport
06/28/2007WO2007071562A1 Sandwich sensor for the determination of an analyte concentration
06/28/2007WO2007071390A1 Method for treating malignant melanoma
06/28/2007WO2007071377A1 Conversion reagent and method and kit for determining haemoglobin
06/28/2007WO2007071367A1 Use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer
06/28/2007WO2007071366A1 Method of assessing colorectal cancer by measuring hemoglobin and m2-pk in a stool sample
06/28/2007WO2007071347A2 Selective marking of immunoglobulin glycans
06/28/2007WO2007071257A1 Method for dissolution testing of pharmaceutical products
06/28/2007WO2007071250A2 Method for detection of l523s expression in biological samples
06/28/2007WO2007071092A1 Blood glucose sensor based on reflection or transmission spectroscopy at frequencies in the terahertz region and above the terahertz region
06/28/2007WO2007071062A1 Methods and compositions for the detection and isolation of ligands
06/28/2007WO2007071061A1 Methods for generating and screening fusion protein libraries and uses thereof
06/28/2007WO2007071060A1 Method for the identification of macromolecule targets of analytes
06/28/2007WO2007071051A1 Novel cancer-associated antigen
06/28/2007WO2007071045A1 Catecholamine regulated protein
06/28/2007WO2007071029A1 Hepatitis c virus ns2/3 assay
06/28/2007WO2007070996A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis
06/28/2007WO2007070965A1 Quantitative trait loci for bovine net feed intake
06/28/2007WO2007051975A3 Compositions comprising igbpma and uses thereof
06/28/2007WO2007051941A3 Method for determining the content of diesel fuel in a lubricating oil of a combustion engine
06/28/2007WO2007051068A3 Compositions and methods for the treatment of aberrant stress response disorders
06/28/2007WO2007050569A3 Polypeptide multilayer films and methods
06/28/2007WO2007049977A3 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases.
06/28/2007WO2007044756A3 Monoclonal antibodies recognizing human ccr8
06/28/2007WO2007044025A9 Method for detecting analytes based on evanescent illumination and scatter-based detection of nonoparticle probe complexes
06/28/2007WO2007038486A3 Gamma secretase notch biomarkers
06/28/2007WO2007035950A3 Matrix-based screening methods and multiple-gene knockdown using rna interference agents
06/28/2007WO2007033395A3 Device for measuring at least one volatile component of an aqueous solution, in particular for measuring alcohol
06/28/2007WO2007031769A3 Gas sensor
06/28/2007WO2007030523A3 Kinetic biomarker for quantification of lymphoproliferation, clonal expansion, recruitment and trafficking in lymphoid tissues and of the in vivo actions of antigens and modulating agents thereon
06/28/2007WO2007028998A3 Method for determining a scaling factor for an output of an electrochemical cell
06/28/2007WO2007027614A3 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient
06/28/2007WO2007022281A3 Microfluidic pi-based molecular sorting
06/28/2007WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza
06/28/2007WO2007018551A3 External modification of composite organic inorganic nanoclusters
06/28/2007WO2007016665A3 Single use fluorescent assays for determination of analytes
06/28/2007WO2007016157A3 Methods and apparatus for identifying live eggs
06/28/2007WO2007013480A3 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex
06/28/2007WO2007013479A3 Genes and polypeptides relating to prostate cancers
06/28/2007WO2007008690A3 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2
06/28/2007WO2007007100A3 Measurement of gastric acid secretion
06/28/2007WO2007002069A3 Serum biomarkers for breast cancer
06/28/2007WO2007001358A3 Fluorescence polarization assays for determining clostridial toxin activity
06/28/2007WO2006137891A3 Membrane with nanochannels for detection of molecules
06/28/2007WO2006132701A3 Methods and kits for regulation of microtubule assembly and dendrite growth and branching
06/28/2007WO2006128593A3 Method for identifying fungicidally active compounds that are based on ipp isomerases
06/28/2007WO2006125021A3 Fibrinogen alpha and hemoglobin polypeptides as cancer markers
06/28/2007WO2006123343A3 Biologically active metal-coated proteins
06/28/2007WO2006122077A3 Method of screening for drugs that block ligand binding to a lipid binding protein
06/28/2007WO2006119424A3 Method and apparatus for detecting the presence of elemental mercury in a gas sample
06/28/2007WO2006113703A3 Carboline derivatives useful in the treatment of cancer
06/28/2007WO2006099543A3 Methods for assessing antibody-mediated cytotoxicity
06/28/2007WO2006090385A3 Protease inhibitors and method of screening thereof
06/28/2007WO2006078911A3 Gitr antibodies for the diagnosis of nsclc
06/28/2007WO2006065943A3 In-vivo monitoring of circulating apoptotic cells
06/28/2007WO2006055096A3 Apparatus and method for processing biological liquids